Trials / Completed
CompletedNCT00333814
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 229 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | Dexamethasone 350 µg; injection drug delivery system at Day 0 |
| DRUG | dexamethasone | Dexamethasone 700 µg injection drug delivery system at Day 0 |
| DRUG | Sham injection | Sham injection at Day 0 |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2008-12-01
- Completion
- 2009-04-01
- First posted
- 2006-06-06
- Last updated
- 2011-04-14
- Results posted
- 2011-04-14
Locations
18 sites across 18 countries: United States, Australia, Austria, Brazil, Canada, Czechia, France, Germany, Greece, India, Israel, Poland, Portugal, South Africa, South Korea, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00333814. Inclusion in this directory is not an endorsement.